Boise Kidney and Hypertension Institute

Meridian, Idaho 83642

0 studies enrolling now · 8 studies all time

What they study most

Atrial Fibrillation, Chronic Kidney Disease, Chronic Renal Failure, Chronic Renal Insufficiency, Diabetes Complications, Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetic Nephropathies, End Stage Renal Disease, Endocrine System Diseases, Glomerulonephritis, Glomerulosclerosis, Focal Segmental

Studies at this site

• A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease — Completed
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease — Stopped early
• Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation — Completed
• This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses) — Completed
• CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes — Completed
• A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy — Completed
• Treatment of Uremic Pruritus With PA101B — Completed
• Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease — Completed